May 7, 2018 / 12:10 PM / 7 months ago

BRIEF-Rexahn Pharmaceuticals Q1 Loss Per Share $0.07

Rexahn Pharmaceuticals Inc:

* Q1 LOSS PER SHARE $0.07

* AS OF MAY 4, 2018, HAD $19.3 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS

* EXPECTS CASH, CASH EQUIVALENTS, INVESTMENTS TO BE SUFFICIENT TO FUND CASH FLOW REQUIREMENTS INTO MID-2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below